524075 Stock Overview
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India.
Albert David Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₹565.00|
|52 Week High||₹738.40|
|52 Week Low||₹485.40|
|1 Month Change||3.49%|
|3 Month Change||5.48%|
|1 Year Change||-4.14%|
|3 Year Change||52.21%|
|5 Year Change||98.07%|
|Change since IPO||3,907.09%|
Recent News & Updates
|524075||IN Pharmaceuticals||IN Market|
Return vs Industry: 524075 exceeded the Indian Pharmaceuticals industry which returned -13.2% over the past year.
Return vs Market: 524075 underperformed the Indian Market which returned 2% over the past year.
|524075 Average Weekly Movement||4.0%|
|Pharmaceuticals Industry Average Movement||5.3%|
|Market Average Movement||5.9%|
|10% most volatile stocks in IN Market||9.1%|
|10% least volatile stocks in IN Market||3.8%|
Stable Share Price: 524075 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 524075's weekly volatility (4%) has been stable over the past year.
About the Company
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company also exports its products to Latin American, Southeast Asian, and other African countries.
Albert David Limited Fundamentals Summary
|524075 fundamental statistics|
Is 524075 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|524075 income statement (TTM)|
|Cost of Revenue||₹1.20b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||46.55|
|Net Profit Margin||8.16%|
How did 524075 perform over the long term?See historical performance and comparison